创金合信全球医药生物股票发起(QDII)A(018155)份额变动
| 截止日 |
期初份额(份) |
期末份额(份) |
期间申购份额(份) |
期间赎回份额(份) |
| 2025-12-30 |
9,334,788.48 |
61,160,171.70 |
71,750,900.56 |
19,925,517.34 |
| 2025-09-29 |
6,228,738.46 |
9,334,788.48 |
4,693,096.04 |
1,587,046.02 |
| 2025-06-29 |
6,301,856.87 |
6,228,738.46 |
727,043.09 |
800,161.50 |
| 2025-03-30 |
6,795,522.15 |
6,301,856.87 |
1,329,236.08 |
1,822,901.36 |
| 2024-12-30 |
6,325,589.89 |
6,795,522.15 |
1,492,031.49 |
1,022,099.23 |
| 2024-09-29 |
6,200,098.26 |
6,325,589.89 |
267,527.14 |
142,035.51 |
| 2024-06-29 |
6,287,150.53 |
6,200,098.26 |
160,554.43 |
247,606.70 |
| 2024-03-30 |
5,342,620.77 |
6,287,150.53 |
963,864.21 |
19,334.45 |
微信公众号
证券之星APP
基本资料
